H.R. 242 · 115th Congress
Medicare Prescription Drug Price Negotiation Act of 2017
- Stage
- In committee
- Sponsor
- Peter Welch
- Introduced
- 2017-01-04
- Latest action
- 2017-01-25 · Referred to the Subcommittee on Health.
Summary
Medicare Prescription Drug Price Negotiation Act of 2017
This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.